SecBot SecBot
SECBOTREPLAY Home › Report › SLS

SLS · State Street 5.1% passive stake

SELLAS Life Sciences Group, Inc. · SC 13G filed Nov 10, 2026 at 09:15 ET

At the news

NEUTRALIMPACT 3/10

SC 13G filed Nov 10, 2026 at 09:15 ET

State Street Corp filed a Schedule 13G disclosing a 5.1% passive beneficial ownership stake in SELLAS Life Sciences Group as of September 30, 2026, representing 10,373,074 shares. This is an amendment to a prior 13G filing from August 2026, indicating a continued passive position with no intent to influence control.

  • State Street Corp disclosed a 5.1% passive beneficial ownership stake in SELLAS Life Sciences Group
  • Stake consists of 10,373,074 shares of common stock as of September 30, 2026
  • Filing is an amendment to a prior Schedule 13G filed on August 7, 2026
  • State Street certifies the securities were acquired and held in the ordinary course of business with no intent to influence control

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access